Literature DB >> 27152962

Animal models to achieve an HIV cure.

Nitasha Kumar1, Ann Chahroudi, Guido Silvestri.   

Abstract

PURPOSE OF REVIEW: The introduction of effective antiretroviral therapy (ART) has transformed HIV infection from a deadly to a chronic infection. Despite its successes in reducing mortality, ART fails to cure HIV allowing HIV to persist in vivo. HIV persistence under ART is thought to be mediated by a combination of latent infection of long-lived cells, homeostatic proliferation of latently infected cells, anatomic sanctuaries, and low-level virus replication. To understand the contribution of specific cell types and anatomic sites to virus persistence in vivo animal models are necessary. RECENT
FINDINGS: The advancements in ART and our understanding of animal models have facilitated the development of models of HIV persistence in nonhuman primates and mice. Simian immunodeficiency virus (SIV) or simian/HIV infection (SHIV) of rhesus and pigtail macaques followed by effective ART represents the most faithful animal model of HIV persistence. HIV infection of humanized mice also provides a useful model for answering specific questions regarding virus persistence in a uniquely mutable system.
SUMMARY: In this review, we describe the most recent findings using animal models of HIV persistence. We will first describe the important aspects of HIV infection that SIV/SHIV infection of nonhuman primates are able to recapitulate, then we will discuss some recent studies that have used these models to understand viral persistence.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27152962      PMCID: PMC4922307          DOI: 10.1097/COH.0000000000000290

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  81 in total

1.  Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy.

Authors:  Mariko Horiike; Shingo Iwami; Makoto Kodama; Akihiko Sato; Yuji Watanabe; Mika Yasui; Yuki Ishida; Takeshi Kobayashi; Tomoyuki Miura; Tatsuhiko Igarashi
Journal:  Virology       Date:  2011-12-21       Impact factor: 3.616

2.  CCR5-Δ32 Heterozygosity, HIV-1 Reservoir Size, and Lymphocyte Activation in Individuals Receiving Long-term Suppressive Antiretroviral Therapy.

Authors:  Timothy J Henrich; Emily Hanhauser; Linda J Harrison; Christine D Palmer; Marisol Romero-Tejeda; Stephanie Jost; Ronald J Bosch; Daniel R Kuritzkes
Journal:  J Infect Dis       Date:  2015-10-28       Impact factor: 5.226

3.  A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy.

Authors:  Adam M Spivak; Adriana Andrade; Evelyn Eisele; Rebecca Hoh; Peter Bacchetti; Namandjé N Bumpus; Fatemeh Emad; Robert Buckheit; Elinore F McCance-Katz; Jun Lai; Margene Kennedy; Geetanjali Chander; Robert F Siliciano; Janet D Siliciano; Steven G Deeks
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

4.  Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial.

Authors:  Thomas A Rasmussen; Martin Tolstrup; Christel R Brinkmann; Rikke Olesen; Christian Erikstrup; Ajantha Solomon; Anni Winckelmann; Sarah Palmer; Charles Dinarello; Maria Buzon; Mathias Lichterfeld; Sharon R Lewin; Lars Østergaard; Ole S Søgaard
Journal:  Lancet HIV       Date:  2014-09-15       Impact factor: 12.767

Review 5.  Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS.

Authors:  Maria M Bednar; Christa Buckheit Sturdevant; Lauren A Tompkins; Kathryn Twigg Arrildt; Elena Dukhovlinova; Laura P Kincer; Ronald Swanstrom
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

6.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

Review 7.  In vivo platforms for analysis of HIV persistence and eradication.

Authors:  J Victor Garcia
Journal:  J Clin Invest       Date:  2016-02-01       Impact factor: 14.808

8.  Generation of HIV latency in humanized BLT mice.

Authors:  Paul W Denton; Rikke Olesen; Shailesh K Choudhary; Nancy M Archin; Angela Wahl; Michael D Swanson; Morgan Chateau; Tomonori Nochi; John F Krisko; Rae Ann Spagnuolo; David M Margolis; J Victor Garcia
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

9.  Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21.

Authors:  Suresh Pallikkuth; Luca Micci; Zachary S Ende; Robin I Iriele; Barbara Cervasi; Benton Lawson; Colleen S McGary; Kenneth A Rogers; James G Else; Guido Silvestri; Kirk Easley; Jacob D Estes; Francois Villinger; Savita Pahwa; Mirko Paiardini
Journal:  PLoS Pathog       Date:  2013-07-04       Impact factor: 6.823

10.  Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.

Authors:  Gregory M Laird; Evelyn E Eisele; S Alireza Rabi; Jun Lai; Stanley Chioma; Joel N Blankson; Janet D Siliciano; Robert F Siliciano
Journal:  PLoS Pathog       Date:  2013-05-30       Impact factor: 6.823

View more
  31 in total

1.  In Vivo Validation of the Viral Barcoding of Simian Immunodeficiency Virus SIVmac239 and the Development of New Barcoded SIV and Subtype B and C Simian-Human Immunodeficiency Viruses.

Authors:  Sirish Khanal; Christine M Fennessey; Sean P O'Brien; Abigail Thorpe; Carolyn Reid; Taina T Immonen; Rodman Smith; Julian W Bess; Adrienne E Swanstrom; Gregory Q Del Prete; Miles P Davenport; Afam A Okoye; Louis J Picker; Jeffrey D Lifson; Brandon F Keele
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

2.  Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.

Authors:  David Palesch; Steven E Bosinger; Maud Mavigner; James M Billingsley; Cameron Mattingly; Diane G Carnathan; Mirko Paiardini; Ann Chahroudi; Thomas H Vanderford; Guido Silvestri
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

Review 3.  Nonhuman primate models of human viral infections.

Authors:  Jacob D Estes; Scott W Wong; Jason M Brenchley
Journal:  Nat Rev Immunol       Date:  2018-06       Impact factor: 53.106

Review 4.  SIV Latency in Macrophages in the CNS.

Authors:  Lucio Gama; Celina Abreu; Erin N Shirk; Suzanne E Queen; Sarah E Beck; Kelly A Metcalf Pate; Brandon T Bullock; M Christine Zink; Joseph L Mankowski; Janice E Clements
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

5.  Brain macrophages harbor latent, infectious simian immunodeficiency virus.

Authors:  Celina Abreu; Erin N Shirk; Suzanne E Queen; Sarah E Beck; Lisa M Mangus; Kelly A M Pate; Joseph L Mankowski; Lucio Gama; Janice E Clements
Journal:  AIDS       Date:  2019-12-01       Impact factor: 4.177

6.  Novel Transmitted/Founder Simian-Human Immunodeficiency Viruses for Human Immunodeficiency Virus Latency and Cure Research.

Authors:  Anya M Bauer; Widade Ziani; Emily Lindemuth; Leticia Kuri-Cervantes; Hui Li; Fang-Hua Lee; Meagan Watkins; Wenge Ding; Huanbin Xu; Ronald Veazey; Katharine J Bar
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

7.  Antibody-Mediated CD4 Depletion Induces Homeostatic CD4+ T Cell Proliferation without Detectable Virus Reactivation in Antiretroviral Therapy-Treated Simian Immunodeficiency Virus-Infected Macaques.

Authors:  Nitasha A Kumar; Julia B McBrien; Diane G Carnathan; Maud Mavigner; Cameron Mattingly; Erick R White; Federico Viviano; Steve E Bosinger; Ann Chahroudi; Guido Silvestri; Mirko Paiardini; Thomas H Vanderford
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

8.  The Establishment of an In Vivo HIV-1 Infection Model in Humanized B-NSG Mice.

Authors:  Tian-Jiao Fan; Li Sun; Xian-Guang Yang; Xia Jin; Wei-Wei Sun; Jian-Hua Wang
Journal:  Virol Sin       Date:  2019-12-21       Impact factor: 4.327

9.  μ-Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies.

Authors:  Hannah S Sperber; Padma Priya Togarrati; Kyle A Raymond; Mohamed S Bouzidi; Renata Gilfanova; Alan G Gutierrez; Marcus O Muench; Satish K Pillai
Journal:  FASEB J       Date:  2020-09-09       Impact factor: 5.191

10.  In vitro models of HIV-1 infection of the Central Nervous System.

Authors:  Celeste Faia; Karlie Plaisance-Bonstaff; Francesca Peruzzi
Journal:  Drug Discov Today Dis Models       Date:  2019-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.